Download Citation
Article Source:
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
Tsivgoulis G,
Katsanos AH,
Mavridis D,
Grigoriadis N,
Dardiotis E,
et al.
(2016)
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.
PLOS ONE 11(9): e0163296.
https://doi.org/10.1371/journal.pone.0163296